Pneumonia due to methicillin-resistant Staphylococcus aureus: clinical features, diagnosis and management
- 1 May 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 15 (3), 218-222
- https://doi.org/10.1097/mcp.0b013e3283292666
Abstract
Purpose of review The review highlights the clinical findings and the management of community-acquired, health-care associated and nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA). Recent findings Although previously considered as a purely nosocomial event, community-acquired MRSA pneumonia is underestimated and is spreading worldwide. A retrospective study showed that almost half of patients with nonnosocomial MRSA pneumonia admitted to a large teaching hospital did not present established criteria for healthcare-associated infections. Recent data show that MRSA ventilator-associated pneumonia is associated with significantly higher mortality than ventilator-associated pneumonia caused by methicillin-susceptible Staphylococcus aureus. Therefore, prompt and appropriate therapy is essential. The optimal therapy for MRSA pneumonia has not been fully elucidated. Although vancomycin has been considered the gold standard for the treatment of MRSA infections, clinical failures have also been reported in the presence of in-vitro susceptibility. Linezolid may provide improved outcomes compared with vancomycin in patients with MRSA pneumonia, but validation in a prospective trial is currently lacking. Recently licensed tigecycline and dalbavancin, a drug in phase III trial, look promising. Animal models showed that immunization against a cytolytic toxin secreted by most Staphylococcus aureus strains protects against lethal pneumonia. Summary Rapid recognition of possible staphylococcal infection in patients with severe pneumonia is essential. The treatment of MRSA pneumonia must be prompt and effective in order to allow a fast microbiological clearance and to successfully manage the infection.Keywords
This publication has 40 references indexed in Scilit:
- Empyema Necessitatis Due to Methicillin-Resistant Staphylococcus aureus : Case Report and Review of the LiteratureJournal of Clinical Microbiology, 2008
- THE CHANGING EPIDEMIOLOGY OF NON-NOSOCOMIAL STAPHYLOCOCCUS AUREUS PNEUMONIAChest, 2008
- Risk of Infection and Death due to Methicillin‐ResistantStaphylococcus aureusin Long‐Term CarriersClinical Infectious Diseases, 2008
- Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in AustraliaInternational Journal of Antimicrobial Agents, 2008
- Community-Acquired Pneumonia and Bacteremia Due to Methicillin-ResistantStaphylococcus aureusCarrying Panton-Valentine-Leukocidin Gene in Greece: Two Case Reports and Literature ReviewJournal of Chemotherapy, 2007
- Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing PneumoniaScience, 2007
- Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumoniaCritical Care, 2006
- Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threatThe Lancet Infectious Diseases, 2005
- Bacteremic Pneumonia Due to Staphylococcus aureus: A Comparison of Disease Caused by Methicillin-Resistant and Methicillin-Susceptible OrganismsClinical Infectious Diseases, 1999
- Clinical and Epidemiologic Investigations of Nosocomial Pulmonary Infections Caused by Methicillin-Resistant Staphylococcus aureusChest, 1994